Health-Care Investors Bank on Congress Snarling RFK Jr.’s Plans
In particular, obesity drugmakers aren’t likely to experience any disruption under the Trump administration, according to Jeff Jonas, a portfolio manager at Gabelli Funds. Seniors should continue to get access to GLP-1s like Ozempic, and Medicare is likely to cover the drugs to treat different co-morbidities once the medications get the go-ahead beyond their existing […]
Nvidia Stock Gains. It Faces This Headache Alongside AI Chip Export Restrictions.
“Nvidia…have sized ‘Sovereign AI’ as a low-double-digit billion-dollar revenue effort this year. Some portion of that total likely includes sales to “Tier 2” countries, which could face new restrictions if the new rules are enacted and enforced,” said John Belton, portfolio manager at Gabelli Funds.
Big tech leader slams President Biden for new AI policy proposals
Ryuta Makino, Research Analyst at Gabelli Funds discussed the Biden administration’s new rules for AI chip exports, speculating that “there may be ways to get around the restrictions at least for the tier 2 countries.”
Increased economic uncertainty will drive gold to $3,000, interest in miners to grow
In a recent interview with Kitco News, Chris Mancini, associate portfolio manager of the Gabelli Gold Fund (GOLDX), said that the main catalyst he is watching is ongoing economic uncertainty and its impact on consumer prices.
Why investors are lending MicroStrategy billions of dollars at 0% interest so it can buy bitcoin
If bitcoin goes to the moon, a niche group of convertible-bond investors will win out. If the crypto tanks, they can ask for their money back early.
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
Jeff Jonas, portfolio manager at Gabelli Funds, is cautious on the deal, mostly due to antitrust concerns. ‘JNJ has a late-stage Depression drug and has always been a leader in Schizophrenia
J&J doubles down on neurological drugs with $14.6 billion Intra-Cellular deal
I do have a lot of antitrust concerns about this deal
Johnson & Johnson makes $15 billion bet on mental-health drugs
Jeff Jonas, portfolio manager at Gabelli Funds, said he’s “cautious” on whether J&J’s purchase of Intra-Cellular Therapies will clear regulatory hurdles.
Stock market’s ‘Trump bump’ nearly erased thanks to bond selloff. What’s next.
“I think the most recent episode we’ve had in yields is more about inflation data than concerns about the fiscal outlook…when it comes to the fiscal outlook, I’m not sure how much has changed,” said John Belton, portfolio manager at Gabelli Funds, in a phone interview.
Constellation Energy to buy Calpine in blockbuster $16.4 billion US power deal
The combination makes CEG bigger in Texas (up to 25% of capacity from 15%)
The Stock Market’s New Year Is Off to a Tough Start. What Lies Ahead, According to Our Roundtable Pros.
Gabelli: To set the stage, we have a $115 trillion global economy. The U.S. is No. 1, with a 26% share. The European Union’s share has dropped to 17.6%, and China is 16.9%. So, how do we grow the world?
Inflation data will be of paramount importance in the week ahead, with earnings kicking off
A hotter inflation report could also weigh on the bond market. John Belton, a portfolio manager at Gabelli Funds, said he’s eyeing the 10-year U.S. Treasury, as it currently sits “not too far” from the psychologically important 5% level.